Aklillu E - Search Results

1

Reduced efficacy of single-dose albendazole against Ascaris lumbricoides, and Trichuris trichiura, and high reinfection rate after cure among school children in southern Ethiopia: a prospective cohort study.

Gebreyesus TD, Makonnen E, Tadele T, Mekete K, Gashaw H, Gerba H, Aklillu E. Gebreyesus TD, et al. Among authors: aklillu e. Infect Dis Poverty. 2024 Jan 22;13(1):8. doi: 10.1186/s40249-024-01176-6. Infect Dis Poverty. 2024. PMID: 38246985 Free PMC article.

2

PharmGKB summary: caffeine pathway.

Thorn CF, Aklillu E, McDonagh EM, Klein TE, Altman RB. Thorn CF, et al. Among authors: aklillu e. Pharmacogenet Genomics. 2012 May;22(5):389-95. doi: 10.1097/FPC.0b013e3283505d5e. Pharmacogenet Genomics. 2012. PMID: 22293536 Free PMC article. No abstract available.

3

Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patients.

Mukonzo JK, Kengo A, Kutesa B, Nanzigu S, Pohanka A, McHugh TD, Zumla A, Aklillu E. Mukonzo JK, et al. Among authors: aklillu e. Trans R Soc Trop Med Hyg. 2020 Feb 7;114(2):107-114. doi: 10.1093/trstmh/trz108. Trans R Soc Trop Med Hyg. 2020. PMID: 31789383

4

Mutations in CYP1B1 cause primary congenital glaucoma by reduction of either activity or abundance of the enzyme.

Chavarria-Soley G, Sticht H, Aklillu E, Ingelman-Sundberg M, Pasutto F, Reis A, Rautenstrauss B. Chavarria-Soley G, et al. Among authors: aklillu e. Hum Mutat. 2008 Sep;29(9):1147-53. doi: 10.1002/humu.20786. Hum Mutat. 2008. PMID: 18470941

5

The VKORC1 Asp36Tyr variant and VKORC1 haplotype diversity in Ashkenazi and Ethiopian populations.

Sominsky S, Korostishevsky M, Kurnik D, Aklillu E, Cohen Y, Ken-Dror G, Loebstein R, Halkin H, Gak E. Sominsky S, et al. Among authors: aklillu e. J Appl Genet. 2014 May;55(2):163-71. doi: 10.1007/s13353-013-0189-2. Epub 2014 Jan 15. J Appl Genet. 2014. PMID: 24425227

6

Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype.

Jiang Z, Dragin N, Jorge-Nebert LF, Martin MV, Guengerich FP, Aklillu E, Ingelman-Sundberg M, Hammons GJ, Lyn-Cook BD, Kadlubar FF, Saldana SN, Sorter M, Vinks AA, Nassr N, von Richter O, Jin L, Nebert DW. Jiang Z, et al. Among authors: aklillu e. Pharmacogenet Genomics. 2006 May;16(5):359-67. doi: 10.1097/01.fpc.0000204994.99429.46. Pharmacogenet Genomics. 2006. PMID: 16609368

7

Recent Progress in Drug Metabolism Research.

Aklillu E, Hidestrand M, Ingelman-Sundberg M, Malmebo S, Westlind A. Aklillu E, et al. Drug News Perspect. 2002 Oct;15(8):528-534. Drug News Perspect. 2002. PMID: 12677192

8

Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines.

Ozdemir V, Aklillu E, Mee S, Bertilsson L, Albers LJ, Graham JE, Caligiuri M, Lohr JB, Reist C. Ozdemir V, et al. Among authors: aklillu e. Expert Opin Pharmacother. 2006 Feb;7(2):119-33. doi: 10.1517/14656566.7.2.119. Expert Opin Pharmacother. 2006. PMID: 16433578 Review.

9

VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals.

Aklillu E, Leong C, Loebstein R, Halkin H, Gak E. Aklillu E, et al. Blood. 2008 Apr 1;111(7):3903-4. doi: 10.1182/blood-2008-01-135863. Blood. 2008. PMID: 18362220 Free article. No abstract available.

10

Analysis of CYP2C9*5 in Caucasian, Oriental and black-African populations.

Yasar U, Aklillu E, Canaparo R, Sandberg M, Sayi J, Roh HK, Wennerholm A. Yasar U, et al. Among authors: aklillu e. Eur J Clin Pharmacol. 2002 Nov;58(8):555-8. doi: 10.1007/s00228-002-0518-6. Epub 2002 Nov 1. Eur J Clin Pharmacol. 2002. PMID: 12451434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page